Absence Seizures
📧 Sign up to get email alerts when something new happens for Absence Seizures.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2011-04-25FDA Approved: ZARONTIN — Supplemental Application (Parke-Davis Div of Pfizer Inc)
FDA approves a supplemental application for Zarontin (ethosuximide) from Parke-Davis Div of Pfizer to update the product labeling.